MBX Biosciences Opens At $23, IPO Priced At $16
MBX Biosciences (MBX) Opens At $23, IPO Priced At $16 This post appeared first on investing.com
Trudeau says government will not intervene in Air Canada dispute with pilots
OTTAWA (Reuters) – The Canadian government will not intervene to end a dispute between Air Canada and its pilots and…
Ratings agency Fitch says extended strike at Boeing poses downgrade risk
(Reuters) -Fitch said on Friday an extended strike at Boeing (NYSE:BA) could pose a credit ratings downgrade risk and would…
Putin’s commodities ban threat puzzles Russian firms and officials
By Gleb Bryanski, Darya Korsunskaya and Gleb Stolyarov MOSCOW (Reuters) – Russian officials and managers are perplexed by President Vladimir…
Exclusive-EU break-up order to Google unlikely for now, sources say
BRUSSELS (Reuters) – EU antitrust officials are considering an order to Alphabet (NASDAQ:GOOGL) unit Google to stop its anti-competitive practices…
Russia’s central bank warns Western banks not to discriminate against Russian clients
MOSCOW (Reuters) – Russia’s central bank has sent a stark warning to subsidiaries of Western banks remaining in Russia not…
This German chip stock is a Best Idea for the Q4 at Bernstein
Investing.com — Bernstein named Infineon (OTC:IFNNY) Technologies AG as its “Best Idea” for the fourth quarter of 2024, signaling confidence…
Wall St muted as hot PPI keeps smaller rate cut in view; Moderna slumps
By Shashwat Chauhan and Lisa Pauline Mattackal (Reuters) – Wall Street was little changed on Thursday after hot producer prices…
Air Canada says government should be ready to prevent pilots from striking
(Reuters) – Air Canada said on Thursday that the federal Canadian government should be prepared to intervene to prevent a…
Microsoft says productivity software suite recovering after outage
(Reuters) -Microsoft said its cloud-based software suite was recovering after an outage impacted thousands of its users on Thursday. “We’ve…